Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length

21 May 2024

Abstract excerpt

BACKGROUND: Large B-cell lymphoma (LBCL) is the most common lymphoma and is known to be a biologically heterogeneous disease regarding genetic, phenotypic, and clinical features. Although the prognosis is good, one-third has a primary refractory or relapsing disease which underscores the importance of developing predictive biological markers capable of identifying high- and low-risk patients. DNA methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Epigenetics and DNA Methylation
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38773655
DOI: 10.1186/s13148-024-01680-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere lengthPMID 38773655Read ↗

Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor MicroenvironmentSemantic proximity Read ↗

The epigenetic basis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.Semantic proximity Read ↗

The many layers of epigenetic dysfunction in B-cell lymphomas.Semantic proximity Read ↗

Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.Semantic proximity Read ↗

The EBV-Positive Tumor Methylome is Distinct from EBV-Negative in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.Semantic proximity Read ↗

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosisSemantic proximity Read ↗

Biological and clinical determinants shaping heterogeneity in mantle cell lymphomaSemantic proximity Read ↗

Methylation alterations and advance of treatment in lymphomaSemantic proximity Read ↗

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.